Doron Therapeutics Positive Phase 2 End Of Phase Meeting 2025

Doron Therapeutics Announces Positive End-of-Phase 2 and Initial RMAT Meeting With FDA for MOTYS (PTP-001) in the Treatment of Knee Osteoarthritis

May 20, 2025

CHAPEL HILL, NORTH CAROLINA / ACCESS Newswire / May 20, 2025 / Doron Therapeutics, a clinical-stage biotechnology company focused on regenerative therapies for musculoskeletal diseases, today announced the…

Latest News

Obviohealth Announces A Groundbreaking Partnership With Dedalus Group To Unite Real World & Clinical Trial Data

DIGITAL CLINICAL SOLUTION

ObvioHealth Announces a Groundbreaking Partnership with Dedalus Group to Unite Real World & Clinical Trial Data

June 7, 2021

Leveraging Next Gen Tools In Rare Disease Research

R&D SERVICES/CRO

Leveraging Next-Gen Tools in Rare Disease Research

March 1, 2021

DIGITAL CLINICAL SOLUTION

Genesis Research Announces Acquisition of Evid Science

January 7, 2021

Fibronostics Raises $8 Million in Series A Financing

August 24, 2020

Fibronostics Appoints Dr. Stephen A. Harrison To Its Board Of Advisors

Fibronostics Appoints Dr. Stephen A. Harrison to its Board of Advisors

August 5, 2020

The Critical Need For Virtual Covid 19 Clinical Trials And Patient Training

DIGITAL CLINICAL SOLUTION

The Critical Need for Virtual COVID-19 Clinical Trials and Patient Training

June 23, 2020

Obviohealth And Hôpital Paris Saint Joseph Announce Partnership To Track Covid 19 In Oncology Patients

DIGITAL CLINICAL SOLUTION

ObvioHealth and Hôpital Paris Saint-Joseph Announce Partnership to Track COVID-19 in Oncology Patients

June 18, 2020

Travecta Therapeutics Announces It Has Closed Its Oversubscribed Series A Round At $27 Million

Travecta Therapeutics Announces it has Closed its Oversubscribed Series A Round at $27 Million

June 11, 2020

Sprim Partners With Health Catalyst To Analyze Covid 19 Impact On Nash And Nafld

R&D SERVICES/CRO

SPRIM Partners with Health Catalyst to Analyze COVID-19 Impact on NASH and NAFLD

June 8, 2020

DIGITAL CLINICAL SOLUTION

ObvioHealth Secures $17 Million in Latest Investment Round

May 20, 2020

Travecta Therapeutics Secures $15 Million in Financing

May 12, 2020

Ventures Day Singapore 2020 Post Event Highlights

Ventures Day Singapore 2020: Post-event highlights

February 10, 2020

Ac Health Announces Investment In Fibronostics

AC Health Announces Investment in Fibronostics

June 7, 2019

Sprim’s Quarterly Ventures Day Meeting In New York

SPRIM’s Quarterly Ventures Day Meeting in New York

March 21, 2019

Objective Gi Funding Announcement

DIGITAL CLINICAL SOLUTION

Objective GI Funding Announcement

January 29, 2019

Tks 1 Investor Day 2019 In Singapore Post Event Highlights

TKS 1 Investor Day 2019 in Singapore: Post Event Highlights

January 28, 2019

Regask, A Healthcare Regtech Startup, Secures Venture Capital Funding In A Seed Round To Pursue Growth

DIGITAL CLINICAL SOLUTION

RegASK, a Healthcare RegTech Startup, Secures Venture Capital Funding in a Seed Round to Pursue Growth

January 15, 2019

Tikehau Capital And Sprim

SPRIM and Tikehau Capital Join Forces with New Singapore-based Life Sciences VC Fund

November 15, 2018

Evid Science Receives Seed Capital To Advance Clinical Ai Platform

DIGITAL CLINICAL SOLUTION

Evid Science Receives Seed Capital to Advance Clinical AI Platform

November 15, 2018

Obviohealth Raises $3 Million In Series A Funding

DIGITAL CLINICAL SOLUTION

ObvioHealth Raises $3 Million in Series A Funding

March 23, 2018

This site uses cookies to offer you a better browsing experience. By browsing this website, you agree to our use of cookies.

Accept